North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 2,331 Jan 1 – Oct 28, 2026
- Disclosed funding
- $260.5B 1933 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| I InScopeCompany profile AI-powered financial reporting platform automating financial statement preparation AI-powered financial reporting platform automating financial statement preparation | $14.5M | Series A | Fintech | United States | Investors | |
| Y Provides AI-powered credit card products for consumers | $200M | Undisclosed | Fintech | United States | Investors | |
| P Provides end-to-end technology platform for independent food distributors | $50M | Series CSeries C+ | Foodtech | United States | Investors | |
| PT Produces rare earth metals and alloys for global customers | $40.2M | Series B3Series B | Climate tech | United States | Investors | |
| EW Eagle WirelessCompany profile Provides cellular modules and full-device solutions for IoT and automotive industries Provides cellular modules and full-device solutions for IoT and automotive industries | $30M | Series B | Hardware | United States | Investors | |
| CM Code MetalCompany profile Provides verifiable code translation and optimization for AI and legacy code across platforms Provides verifiable code translation and optimization for AI and legacy code across platforms | $125M | Series B | Defense tech | United States | Investors | |
| TT Ten63 TherapeuticsCompany profile Develops AI-driven drug discovery platform for first- and best-in-class therapeutics Develops AI-driven drug discovery platform for first- and best-in-class therapeutics | $45M | StrategicUndisclosed | AI | United States | Investors | |
| i Provides financing and dining rewards for restaurants and consumers | $450M | Growth | Foodtech | United States | Investors | |
 Altesa BioSciencesCompany profile Clinical-stage developer of oral antiviral medicines for people with chronic lung disease. Clinical-stage developer of oral antiviral medicines for people with chronic lung disease. | $75M | Series B | Biotech | United States | Investors | |
| L LanzaJetCompany profile Develops technology for producing Sustainable Aviation Fuel (SAF) and other alternative fuels Develops technology for producing Sustainable Aviation Fuel (SAF) and other alternative fuels | $47M | Growth | Climate tech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
135rounds3led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
100rounds20led - 3General Catalyst
Hyperbolic, Re:Build, Provision Labs
74rounds8led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
59rounds0led - 5Khosla Ventures
Arda Industries, Tolan
59rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.